iStent inject Trabecular Micro-Bypass System

FDA Premarket Approval P170043 S007

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval of the revised protocol for the post-approval study (pas) protocol.

DeviceiStent inject Trabecular Micro-Bypass System
Generic NameIntraocular Pressure Lowering Implant
ApplicantGlaukos Corporation
Date Received2020-03-03
Decision Date2020-04-30
PMAP170043
SupplementS007
Product CodeOGO 
Advisory CommitteeOphthalmic
Supplement TypeNormal 180 Day Track No User Fee
Supplement ReasonPostapproval Study Protocol - Ode/oir
Expedited ReviewNo
Combination Product No
Applicant Address Glaukos Corporation 229 Avenida Fabricante san Clemente, CA 92672

Supplemental Filings

Supplement NumberDateSupplement Type
P170043Original Filing
S007 2020-03-03 Normal 180 Day Track No User Fee
S006 2020-03-03 Normal 180 Day Track No User Fee
S005
S004 2019-05-02 30-day Notice
S003
S002 2018-07-23 Normal 180 Day Track No User Fee
S001 2018-07-23 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
00853704002203 P170043 000

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.